Aberrant endochondral bone formation in the physis is a unique bone lesion in neonatal-onset multisystem inflammatory disease (NOMID), also called chronic infantile neurologic cutaneous articular (CINCA), the most severe of the cryopyrin-associated periodic syndrome (CAPS) diseases, which are interleukin-1β (IL-1β)-related monogenic autoinflammatory diseases. The wingless (Wnt) pathway plays an important role in osteoblast differentiation. In this study, we explored the potential role of IL-1β on the expression of WNT genes and the Wnt antagonist Dickkopf-1 (DKK1). The expression of WNT and DKK1 in fibroblast-like synoviocytes (FLS), which are articular resident cells, was quantified by quantitative PCR and enzyme-linked immunosorbent assay. Additionally, we used T cell factor (TCF) reporter assays to evaluate the activity of the canonical Wnt signal pathway in the presence or absence of the supernatant of cultured FLS treated with or without IL-1β and IL-6. Anti-DKK1 antibodies were used to neutralize DKK1. The expression of both canonical and non-canonical WNT genes as well as DKK1 was observed in FLS. The supernatant of cultured FLS suppressed the luciferase activity of the TCF reporter, and this effect was reduced by its pre-treatment with an anti-DKK1 antibody. Both IL-1β and IL-6 significantly reduced DKK1 production. Furthermore, the supernatant of FLS cultured with IL-1β or IL-6 showed a reduced inhibitory effect on Wnt signaling, compared with the supernatant of untreated FLS. These data suggest that IL-1β, like IL-6, dampens DKK1 production, and thereby promotes Wnt signal activation. Therefore, increased levels of IL-1β may contribute to the dysregulation of endochondral ossification in NOMID/CINCA.
INTRODUCTION
Cryopyrin-associated periodic syndrome (CAPS) is one of the interleukin (IL)-1β-related monogenic autoinflammatory diseases: it is caused by a gain-offunction mutation in the NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) gene, whose product, in patients with CAPS, activates the inflammasome and promotes the production of mature IL-1β via activation of caspase-1, an IL-1β processing enzyme [1] [2] [3] [4] . CAPS includes familial cold autoinflammatory syndrome (FCAS), MuckleWells syndrome (MWS), and neonatal-onset multisystem inflammatory disease (NOMID) that is also called chronic infantile neurologic cutaneous articular (CINCA) [1] . Canakinumab, an anti-IL-1β monoclonal antibody, is beneficial in the treatment of CAPS [4] [5] [6] [7] , highlighting the importance of IL-1β in its progression.
In addition to common symptoms in CAPS (such as episodic fever, arthritis, and urticarial rash), severe and persistent inflammation causes a serious disability with growth retardation in patients with NOMID/ CINCA, the most severe disease in the CAPS spectrum [1, 5, 8] . Bone lesions, conjunctivitis, hearing loss due to cochlear inflammation, and aseptic meningitis are characteristically observed in NOMID/ CINCA [1, 5, 9] . Analysis of the bone of patients with NOMID/CINCA shows aberrant endochondral bone formation in the physis in the absence of synovitis, a pathological finding different from those in other joint-affecting inflammatory diseases such as juvenile rheumatoid arthritis (JRA) [10, 11] . The histological hallmarks of the bone lesions in NOMID/ CINCA are disorganized cartilaginous columns, inhomogenous spread of chondrocytes, and complementary ossification [10] , suggesting that the bone lesions in NOMID/CINCA are related with the dysregulation of endochondral ossification.
It is interesting that the pathological features of bone lesions in NOMID/CINCA are similar to those found in patients with fibrous dysplasia [5, [9] [10] [11] , a skeletal disease caused by the gain-of-function mutation of the GNAS gene that leads to constitutive activation of Gαs, one of the four Gα protein families utilized for the downstream signaling of G protein-coupled receptors. Regard et al. have reported that GNAS mutation in patients with fibrous dysplasia leads to aberrant activation of the canonical Wnt signal [12] : because this signaling pathway plays important roles in the regulation of cartilage development, growth, and maintenance, it is quite reasonable that its dysregulation causes abnormal cartilage and bone differentiation.
The role of the Wnt signaling in the regulation of osteoblast differentiation has been examined in detail [13] [14] [15] . In the absence of interaction between WNT ligands and the cell surface receptor complex of low-density lipoprotein receptor-related protein 5/6 (LRP5/6) and frizzled (FZD), β-catenin is constitutively phosphorylated by glycogen synthase kinase 3β (GSK-3β) and is recognized by the E3 ubiquitin ligase β-transducin repeat-containing protein (β-Trcp) for degradation by the proteasome in the presence of Axin and adenomatous polyposis coli (APC): this keeps β-catenin at low levels in the cytoplasm and prevents its translocation into the nucleus [15] . Ligation of WNT proteins to the cell surface receptor complex LRP5/6 and FZD inhibits β-catenin phosphorylation by GSK-3β and stabilizes it. β-catenin translocates into the nucleus and associates with T cell factor (TCF) for specific transcriptional activation [15] . The Wnt signaling pathway inhibitor Dickkopf-1 (DKK1) is one of the Wnt antagonists [16] . DKK1 binds to the LRP5/6 receptor and facilitates its internalization, therefore obstructing the interaction between WNT ligands and their receptors [16] .
In the present study, we examined whether IL-1β affects the Wnt signaling for the development of bone lesions in NOMID/CINCA.
MATERIALS AND METHODS

Cell Culture
Normal human bone marrow-derived mesenchymal stem cells (MSC) were purchased from Lonza (Basel, Switzerland) and were grown in MSCGM human Mesenchymal Stem Cell Growth Bulletkit™ Medium (Lonza, Basel, Switzerland). Fibroblast-like synoviocytes (FLS), derived from four patients with rheumatoid arthritis (RA) and therefore called RA-FLS, were purchased from Articular Engineering (Northbrook, IL, USA). FLS from patients with osteoarthritis (OA) and normal subjects (OA-FLS and normal FLS, respectively) were obtained from human knee joints at the time of autopsy from donors, as described previously [17, 18] . Experiments with FLS were carried out at passages 8 to 10.
U2OS cells (osteosarcoma cells) were obtained from American Type Culture Collection (Manassas, VA, USA) and cultured in Dulbecco's modified Eagle's medium (Wako Chemical, Irvine, CA, USA) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich Co., St. Louis, MO, USA) and penicillin (10 units/mL)-streptomycin (10 μg/mL) (Wako Chemical).
Peripheral Blood Mononuclear Cells Preparation
We used Lymphoprep™ (Alere Technologies, Waltham, MA, USA) for the isolation of peripheral blood mononuclear cells (PBMC), according to the manufacturer's protocol. Briefly, peripheral blood diluted 1:1 with 2% FBS in phosphate-buffered saline (PBS) was layered on the Lymphoprep™. After centrifugation at 800g for 20 min at 20-25°C (68-77°F, defined as room temperature [RT]), we collected the PBMC band at the interface between the sample and the Lymphoprep™. After washing with PBS, we extracted total RNA from PBMC, for quantitative polymerase chain reaction (qPCR).
Reagents
Recombinant WNT3A (200 μg/mL), IL-1β (10 μg/ mL), IL-6 (100 μg/mL), and soluble IL-6 receptor (sIL-6R, 100 μg/mL) were purchased from R&D Systems (Minneapolis, MN, USA). Lithium chloride (LiCl, Sigma) was used as an inhibitor of GSK-3, to strongly activate Wnt signaling [19] .
Transfection TOP FLASH, a TCF reporter plasmid for Wnt/β-catenin activity assays, was purchased from Millipore (Burlington, MA, USA). U2OS cells (1 × 10 5 cells/well in a 24-well plate) were transfected with the TCF plasmid for 4 h using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) and OPTI-MEM™ (Life Technologies, Carlsbad, CA, USA).
Luciferase Assays Using the TCF Reporter Plasmid U2OS cells were treated in 24-well plates as described. After transfection, the cells were rinsed with PBS. Passive lysis buffer (100 μL, Promega, Madison, WI, USA) was added into each well. Twenty microliters of cell lysate was used to measure the firefly luciferase activity, after addition of 100 μL of Luciferase Assay Reagent II (LAR II, Promega). Readings of the luciferase activity were obtained using a microplate reader (TECAN, Baldwin Park, CA, USA), programmed to provide a 2-second pre-read delay, followed by a 10-second measurement period.
qPCR Total RNA was extracted from cells using TRIzol reagent (Invitrogen), according to the manufacturer's instructions, and reverse transcribed using the ReverTra Ace qPCR RT kit (TOYOBO, Osaka, Japan). Specific messenger RNAs (mRNA) were quantified through qPCR, using SYBR Green (QIAGEN, Hilden, Germany) and a CFX96 thermal cycler (Bio-Rad, Hercules, CA, USA). The primer sequences used are shown in Supplemental Table 1 . Actin B (ACTB) was used to verify equal loading. The amplification of specific PCR products was confirmed by performing a dissociation curve analysis for each primer pair. The expression of WNT genes and DKK1 in Fig. 1 and that of sclerostin (SOST, data not shown) is calculated as the threshold cycle (Ct) value of ACTB minus that of the target gene: the baseline of ΔCt is set at − 20. Differential gene expression in Fig. 4 was calculated according to the comparative Ct method [20] .
Immunohistochemistry
Synovial tissue samples were obtained during synovectomy from patients with RA (patients had met the American College of Rheumatology 1987 revised criteria [21] ). Sections from paraffinembedded joints were first de-paraffinized in the xylene substitute Pro-Par Clearant (Anatech Ltd., Battle Creek, MI, USA) and rehydrated in graded ethanol and water. For antigen unmasking, sections in 10 mM sodium citrate buffer (pH 6.0) were heated in a microwave oven and kept at 80-85°C for 1.5 min. Slides were cooled for 20 min at RT after antigen unmasking. After washing with PBS, sections were blocked with 5% serum for 30 min at RT and then incubated with goat anti-DKK1 antibody (8 μg) (R&D Systems) overnight at 4°C. After washing with PBS, sections were incubated with a biotinylated anti-goat secondary antibody for 30 min at RT, and then incubated with Vectastain® ABC-AP reagent (Vector Laboratories, Burlingame, CA, USA) for 30 min. Slides were washed, and sections were incubated with an alkaline phosphatase substrate solution for 20-30 min [22] . Slides were then mounted and observed under a BZ-X700 microscope (KEYENCE, Osaka, Japan).
Enzyme-Linked Immunosorbent Assay
The concentration of DKK1 and SOST in the supernatant from FLS was determined by Human Dkk1 ELISA (RayBiotech, Norcross, GA, USA) or Human SOST ELISA (RayBiotech) according to the manufacturer's protocol. The absorbance was measured at 450 nm on the iMark™ Microplate Absorbance Reader (Bio-Rad).
Statistical Analysis
Differences in each experiment were analyzed using the Mann-Whitney U test, Student's T test, or Wilcoxon signed-rank test, as indicated. All reported p values were two-sided and rated as significant only when < 0.05. The XLSTAT software, version 2015.4.01.20767 (Addinsoft, Brooklyn, NY, USA) was used for all calculations.
RESULTS
FLS Express WNT Ligands and DKK1
FLS are articular resident cells that affect articular tissues, such as bone and cartilage. To investigate whether the Wnt signaling plays a role in FLS function, we first examined the expression of components of the Wnt signal in FLS, MSC, PBMC, and U2OS cells. Specifically, we analyzed the expression of WNT2, WNT3, and WNT3A for the canonical Wnt/β-catenin pathway, WNT4, WNT5A, and WNT11 for the non-canonical Wnt pathway [23] , as well as that of SOST and DKK1, two Wnt receptor antagonists. As indicated in Fig. 1a , and in agreement with previously published data [24] , the mRNA of WNT genes was expressed in RA-FLS, OA-FLS, and normal FLS. The expression of WNT3A was not detected in any of the FLS examined. Additionally, the expression levels of the WNT genes in FLS were comparable to those in MSC.
FLS expressed comparable levels of DKK1 with MSC (Fig. 1a, b) , which are known to be a major source of DKK1 in humans [25] . We did not find any remarkable difference in DKK1 expression in RA-FLS, OA-FLS, and normal FLS (Fig. 1a) . Contrarily, U2OS cells and PBMC showed low levels of DKK1 mRNA. The expression of SOST was very low in every cell type examined (data not shown). We also examined the expression of DKK1 protein in vivo. Immunohistological examination revealed DKK1 protein expression in the synovial tissue from patient with RA (Supplemental Figure 1a) . Secreted DKK1 was quantified in FLS culture supernatant (Fig. 1b) . There was no remarkable difference in the amount of DKK1 secreted by RA-FLS, OA-FLS, and normal FLS. Furthermore, DKK1 was below detectable levels in the supernatant of U2OS cells. SOST was not detected in the FLS supernatant (data not shown). Therefore, FLS produce both Wnt ligands and its antagonist DKK1.
FLS Inhibit the Canonical Wnt Pathway
We next questioned whether FLS activate or inhibit the Wnt signaling. We used U2OS, a cell line that does not express DKK1 (Fig. 1a, b) , and the TOP FLASH luciferase reporter plasmid (TCF reporter), which, by measuring the activation of TCF-dependent transcription, allows monitoring of the Wnt signaling (Supplemental Figure 2) . The luciferase activity was detectable, probably because U2OS cells express WNT3 and WNT3A for the activation of the canonical Wnt pathway (Fig. 1a) . The supernatant from RA-FLS cultures was added to U2OS cells that had been previously transfected with the TCF reporter, and the luciferase activity was measured. The transcriptional activity of the TCF reporter was significantly inhibited by the addition of the RA-FLS supernatant (Fig. 2a) .
Next, we conducted an experiment using recombinant WNT3A to confirm the role of RA-FLS on Wnt signal. WNT3A activates the canonical Wnt signaling and is not expressed in any of our FLS (Fig. 1a) . Therefore, activation of Wnt signal by recombinant WNT3A was not supposed to be affected by addition of FLS supernatant. Notably, the reporter activity was increased 5 to 15 folds upon treatment with recombinant WNT3A, and this effect was significantly inhibited by the addition of RA-FLS supernatant (Fig.  2b) . LiCl is known to enhance the activity of the canonical Wnt signal via GSK-3β inhibition [19] and increased the luciferase activity in our assay by 100 to 200 folds. However, the supernatant from RA-FLS cultures significantly suppressed the TCF activity induced by LiCl in a dosedependent manner (Fig. 2c) .
DKK1 from FLS Inhibits the Wnt Signaling
To determine whether DKK1 from FLS plays a role in inhibiting the Wnt signaling, we inactivated DKK1 in the supernatant of RA-FLS using an anti-DKK1 antibody. The neutralizing ability of the antibody was evaluated with western blotting assays following DKK1 immunoprecipitation assays from FLS culture supernatant (Fig. 3a) . Additionally, we confirmed that more than 95% of DKK1 was depleted upon incubation with a DKK1 antibody in ELISA using RA-FLS supernatant and following the protocol described in BMATERIALS AND METHODS^(data not shown). The supernatant of RA-FLS treated with or without the anti-DKK1 antibody was added to U2OS cells transfected with the TCF reporter plasmid. In luciferase reporter assays, we found that the luciferase activity induced by WNT3A and LiCl (Fig. 3b, c, respectively) was inhibited by the RA-FLS supernatant; these results were significantly reversed when the supernatant from RA-FLS was pre-treated with the anti-DKK1 antibody (Fig. 3b, c) .
IL-1β Reduces DKK1 Production and the Inhibitory Effect of FLS on the Wnt Pathway
Next, we examined the effect of IL-1β and IL-6, cytokines that are elevated in CAPS [26] , on the expressions of WNT2, WNT3, WNT4, WNT5A, WNT11, and DKK1 in FLS obtained from four different patients with RA. We used IL-6 as a control because it has been reported that IL-6 suppresses DKK1 production from RA-FLS [27] . The change in the expression of the examined genes varied greatly among the FLS isolated from the different patients; however, there were statistically significant changes in some genes. IL-1β induced WNT2 and WNT5A and IL-6 induced WNT2. Interestingly, IL-1β suppressed the mRNA expression and the secretion of DKK1 (Fig. 4a, b) . IL-6 also suppressed DKK1 production, though less than that of IL-1β (Fig. 4b) .
We lastly examined the effect of the supernatant from FLS treated with IL-1β or IL-6 on Wnt signaling in TCF reporter assays. FLS were cultured in the presence or absence of IL-1β or IL-6 for 24 h; their supernatant was collected and added to U2OS cells transfected with the TCF reporter as described above. We found that the inhibitory effect of FLS on Wnt signaling was attenuated when the FLS were treated with IL-1β or IL-6 (Fig. 4c) , confirming the effect of IL-1β or IL-6 on the Wnt signaling. ossification in the growth plate [28] . The importance of the Wnt signal in human skeletal development is evidenced by the existence of human diseases caused by abnormalities associated with Wnt receptors [15, 29, 30] . Therefore, a dysregulation of the Wnt signal can cause abnormalities in human skeletal development, such as aberrant endochondral bone formation in the physis in NOMID/CINCA [10, 11] .
In the present study, we found that FLS suppress Wnt signal via DKK1 production, and that both IL-1β and IL-6 reduce DKK1 production from the cells and, thereby, activate Wnt signaling (Figs. 1 and 4) . Consistently, it has been reported that components of the Wnt signal are enriched in lesional cells compared with those in nonlesional cells isolated from the bone of a patient with NOMID/CINCA [31] . Therefore, it is possible that the overproduction of IL-1β in patients with NOMID/ CINCA aberrantly activates the Wnt signaling and leads to abnormalities in cartilage and bone differentiation. Interestingly, the bone lesions in NOMID/CINCA are similar to those in fibrous dysplasia, a disease-mediated Wnt signal upregulation upon the gain-of-function mutation of the GNAS gene [5, 10, 12] . In both diseases, the cartilaginous columns are disorganized, and the distribution of the chondrocytes is not homogenous. Our data, consistent with a previous report about fibrous dysplasia [12] , suggest that two distinct genetic mutations in two different diseases lead to similar abnormal activation of the Wnt signaling, and, consequently, similar bone lesions. It was reported that there is a link between IL-1β and the Wnt signal. IL-1β promotes osteoblastogenesis through the non-canonical WNT5A/Ror2 pathway [32] . In the present study, we demonstrated that IL-1β has a positive effect on canonical Wnt signal pathway as well (Fig. 4b) . IL-1β alters the expression levels of both Wnt agonist (WNT2 and WNT5A) and Wnt antagonist (DKK1) genes (Fig. 4a, b) . We argue that the regulation of DKK1 from FLS is critical, because the TCF reporter activation induced by recombinant WNT3A or LiCl is dampened by the addition of supernatant from FLS (Fig. 2) . Therefore, FLS inhibit the canonical Wnt signaling through the secretion of DKK1. DKK1 from FLS occupies most of the LRP5/6 receptor on the cell membrane and suppresses the activation of the canonical Wnt signal, regardless of the levels of Wnt ligands available. Therefore, when considering the influence of pathological conditions on the Wnt signal, it is important to analyze the regulation of DKK1 too.
It is interesting that representative inflammatory cytokines exert different effects on the expression of DKK1. Contrary to IL-1β, tumor necrosis factor (TNF) is known to induce DKK1 [33] . Similarly to IL-1β, IL-6 suppresses the production of DKK1, consistently with the results of a previous study [27] . Although the mechanism through which inflammatory cytokines regulate the expression of DKK1 has not been fully elucidated, it has been reported that IL-1β suppresses the expression of DKK1 through microRNA-433 [34] . A post-transcriptional regulation may contribute to the regulation of DKK1 production by IL-6, because IL-6 decreases DKK1 production from RA-FLS without significantly inhibiting the mRNA expression of DKK1. This speculation is supported by previous reports showing that DKK1 gene expression is regulated at the post-transcriptional level by miRNAor RNA-binding complexes [35, 36] . Further research will clarify the mechanism through which IL-1β, IL-6, and other cytokines regulate DKK1 production.
We found that the expression of DKK1 in FLS is comparable with that in MSC, which produce high levels of DKK1 (Fig. 1a, b) [25] . The expression of DKK1 in FLS seems important to regulate the Wnt signaling in joints and maintain articular homeostasis, because the supernatant of FLS exercised a robust inhibitory effect on the activity of the TCF reporter. The important role of DKK1 from FLS was further confirmed in an assay in which DKK1 had been inactivated with an anti-DKK1 neutralizing antibody (Fig. 3) . Our data suggests that suppression of the Wnt signaling by DKK1 from FLS is important for the normal differentiation of cartilage and bone, whereas the reduction of DKK1 levels by IL-1β may cause inappropriate activation of Wnt signal and abnormal differentiation of cartilage and bone.
Our data also suggests that the supplementation of DKK1 might be beneficial to prevent/treat bone lesions in patients with NOMID/CINCA. Since it is possible to neutralize IL-1β using clinically available antibodies (canakinumab), the administration of DKK1 might be limited to those cases in which canakinumab cannot be used. Notably, it is necessary to demonstrate that the hyperactivation of the Wnt signaling is the main cause of bone lesion of NOMID/CINCA. It is also important to investigate the potential systemic effect of the administration of exogenous DKK1. Further studies are necessary to clarify these issues and prove if the targeting of the Wnt signaling is beneficial in treating bone lesions in NOMID/CINCA. 
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